药品名称DARVON-N
申请号016862产品号002
活性成分PROPOXYPHENE NAPSYLATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格100MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构XANODYNE PHARMACEUTICS INC
化学类型New dosage form审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
016862042APLabel2009/10/01下载
016862042APLetter2009/10/26下载
016862041APLetter2009/11/13下载
016862041APLabel2009/10/01下载
016862041APMedication Guide2009/10/01下载
016862033APLetter2004/06/02下载
016862000APReview2007/04/09下载
016862000APOther2009/11/18下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
016862042AP2009/09/25Labeling Revision
016862041AP2009/09/25Labeling Revision
016862037AP1999/02/24Manufacturing Change or Addition
016862036AP1998/10/05Manufacturing Change or Addition
016862035AP1998/08/10Control Supplement
016862034AP1998/04/02Package Change
016862033AP2002/08/01Labeling Revision
016862032AP1994/04/05Manufacturing Change or Addition
016862031AP1994/09/02Labeling Revision
016862030AP1992/09/15Control Supplement
016862029AP1994/08/23Labeling Revision
016862027AP1987/04/15Control Supplement
016862024AP1986/10/16Labeling Revision
016862023AP1986/04/18Control Supplement
016862021AP1985/12/31Labeling Revision
016862019AP1985/04/16Control Supplement
016862018AP1986/04/21Labeling Revision
016862017AP1984/08/16Control Supplement
016862015AP1981/06/08Labeling Revision
016862013AP1981/01/27Labeling Revision
016862012AP1979/09/26Labeling Revision
016862011AP1980/07/24Formulation Revision
016862010AP1978/01/11Labeling Revision
016862009AP1977/10/13Package Change
016862008AP1977/10/13Package Change
016862007AP1980/01/21Control Supplement
016862000AP1971/09/09Approval